Product Code: ETC13363581 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Opioid Use Disorder Market was valued at USD 4.2 Billion in 2024 and is expected to reach USD 6.9 Billion by 2031, growing at a compound annual growth rate of 6.10% during the forecast period (2025-2031).
The Global Opioid Use Disorder Market is witnessing significant growth driven by the increasing prevalence of opioid addiction worldwide. The market encompasses a range of treatment options, including medications such as buprenorphine, methadone, and naltrexone, as well as behavioral therapies and counseling services. The market is also characterized by ongoing research and development efforts to introduce innovative therapies and improve existing treatment outcomes. Key factors contributing to market growth include rising awareness about the detrimental effects of opioid misuse, government initiatives to combat the opioid crisis, and efforts to reduce the stigma associated with seeking treatment for opioid use disorder. However, challenges such as high treatment costs, limited access to healthcare services in certain regions, and the potential for regulatory hurdles pose obstacles to market expansion.
The Global Opioid Use Disorder Market is witnessing a shift towards increased adoption of medication-assisted treatment (MAT) options, such as buprenorphine and methadone, as well as the development of novel pharmacotherapies like extended-release naltrexone. Growing awareness about the efficacy of MAT in managing opioid addiction, coupled with the rising burden of opioid-related deaths and overdoses, has led to an expansion of treatment options and increased research and development activities in the market. Additionally, the integration of digital health solutions and telemedicine services for remote patient monitoring and support is creating new opportunities for market growth. With a focus on improving access to treatment and reducing stigma associated with opioid use disorder, the market is poised for further advancements in addressing this global public health challenge.
The Global Opioid Use Disorder market faces various challenges, including stigma associated with addiction, limited access to treatment options, regulatory hurdles, and lack of awareness about available therapies. Stigma often prevents individuals from seeking help and accessing effective treatments, while regulatory barriers can hinder the development and approval of new medications. Additionally, the high cost of some treatments and lack of insurance coverage pose financial challenges for patients seeking care. Furthermore, the complex nature of opioid addiction and varying degrees of severity among individuals make it difficult to provide standardized treatment approaches. Addressing these challenges requires a multi-faceted approach involving increased education and awareness, improved access to affordable treatments, and enhanced collaboration among healthcare providers, policymakers, and pharmaceutical companies.
The Global Opioid Use Disorder Market is primarily driven by the increasing prevalence of opioid addiction, fueled by the widespread availability and misuse of prescription opioids. Additionally, the rising awareness about the detrimental effects of opioid abuse on public health has led to a growing demand for effective treatment options. Government initiatives and policies aimed at addressing the opioid crisis, coupled with advancements in pharmaceutical research and development, are further propelling the market growth. The expanding range of treatment modalities, including medication-assisted therapies and behavioral interventions, is also contributing to the market expansion. Furthermore, the growing acceptance of opioid use disorder as a chronic medical condition rather than a moral failing is driving efforts to improve access to care and reduce stigma, thus boosting the market for opioid use disorder treatments.
Government policies related to the Global Opioid Use Disorder Market primarily focus on increasing access to treatment and prevention programs, as well as regulating the prescribing and distribution of opioids to curb misuse and abuse. Policies include the expansion of medication-assisted treatment options, improved training for healthcare providers on prescribing practices, and the implementation of prescription drug monitoring programs to track and prevent over-prescription. Additionally, governments are investing in public health campaigns to raise awareness about the risks of opioid misuse and to reduce stigma surrounding addiction. These policies aim to address the growing opioid epidemic by promoting evidence-based interventions and ensuring that individuals with opioid use disorder receive the support they need to recover and lead healthy lives.
The Global Opioid Use Disorder Market is expected to experience significant growth in the coming years, driven by increasing awareness about the condition and the growing need for effective treatment options. Factors such as the rising prevalence of opioid addiction, expanding healthcare infrastructure, and the development of novel therapies are likely to contribute to market expansion. Additionally, government initiatives aimed at addressing the opioid crisis and improving access to treatment are expected to further boost market growth. However, challenges such as regulatory hurdles, stigma associated with opioid use disorder, and the high cost of treatment may pose limitations to market development. Overall, the market is poised for growth as stakeholders work towards improving patient outcomes and advancing the standard of care for individuals with opioid use disorder.
In the global opioid use disorder market, North America dominates due to the high prevalence of opioid addiction and well-established healthcare infrastructure. The region is witnessing a surge in the adoption of medication-assisted treatment and increasing awareness about the disorder, driving market growth. Europe follows closely behind, with initiatives to expand access to treatment options and reduce opioid-related deaths. In Asia, the market is growing steadily as governments focus on addressing the rising opioid addiction rates through awareness campaigns and treatment programs. The Middle East and Africa region is experiencing a gradual increase in market growth due to improving healthcare facilities and rising awareness. Latin America is also showing promising growth potential, with increasing initiatives to combat opioid addiction and expand treatment services.
Global Opioid Use Disorder Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Opioid Use Disorder Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Opioid Use Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Global Opioid Use Disorder Market - Industry Life Cycle |
3.4 Global Opioid Use Disorder Market - Porter's Five Forces |
3.5 Global Opioid Use Disorder Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Opioid Use Disorder Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Global Opioid Use Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Global Opioid Use Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Global Opioid Use Disorder Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 Global Opioid Use Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Opioid Use Disorder Market Trends |
6 Global Opioid Use Disorder Market, 2021 - 2031 |
6.1 Global Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Opioid Use Disorder Market, Revenues & Volume, By Medication-Assisted Treatment (MAT), 2021 - 2031 |
6.1.3 Global Opioid Use Disorder Market, Revenues & Volume, By Behavioral Therapy, 2021 - 2031 |
6.1.4 Global Opioid Use Disorder Market, Revenues & Volume, By Detoxification, 2021 - 2031 |
6.1.5 Global Opioid Use Disorder Market, Revenues & Volume, By Support Programs, 2021 - 2031 |
6.2 Global Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Opioid Use Disorder Market, Revenues & Volume, By Buprenorphine, 2021 - 2031 |
6.2.3 Global Opioid Use Disorder Market, Revenues & Volume, By Methadone, 2021 - 2031 |
6.2.4 Global Opioid Use Disorder Market, Revenues & Volume, By Naltrexone, 2021 - 2031 |
6.2.5 Global Opioid Use Disorder Market, Revenues & Volume, By Naloxone, 2021 - 2031 |
6.3 Global Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Opioid Use Disorder Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Opioid Use Disorder Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.4 Global Opioid Use Disorder Market, Revenues & Volume, By Specialty Centers, 2021 - 2031 |
6.3.5 Global Opioid Use Disorder Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.4 Global Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Opioid Use Disorder Market, Revenues & Volume, By Long-Term, 2021 - 2031 |
6.4.3 Global Opioid Use Disorder Market, Revenues & Volume, By Outpatient, 2021 - 2031 |
6.4.4 Global Opioid Use Disorder Market, Revenues & Volume, By Residential, 2021 - 2031 |
6.4.5 Global Opioid Use Disorder Market, Revenues & Volume, By Harm Reduction, 2021 - 2031 |
7 North America Opioid Use Disorder Market, Overview & Analysis |
7.1 North America Opioid Use Disorder Market Revenues & Volume, 2021 - 2031 |
7.2 North America Opioid Use Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4 North America Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.5 North America Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6 North America Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
8 Latin America (LATAM) Opioid Use Disorder Market, Overview & Analysis |
8.1 Latin America (LATAM) Opioid Use Disorder Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Opioid Use Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.4 Latin America (LATAM) Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
8.5 Latin America (LATAM) Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8.6 Latin America (LATAM) Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
9 Asia Opioid Use Disorder Market, Overview & Analysis |
9.1 Asia Opioid Use Disorder Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Opioid Use Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.4 Asia Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
9.5 Asia Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9.6 Asia Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
10 Africa Opioid Use Disorder Market, Overview & Analysis |
10.1 Africa Opioid Use Disorder Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Opioid Use Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.4 Africa Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
10.5 Africa Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10.6 Africa Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
11 Europe Opioid Use Disorder Market, Overview & Analysis |
11.1 Europe Opioid Use Disorder Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Opioid Use Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.4 Europe Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
11.5 Europe Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11.6 Europe Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
12 Middle East Opioid Use Disorder Market, Overview & Analysis |
12.1 Middle East Opioid Use Disorder Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Opioid Use Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Opioid Use Disorder Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.4 Middle East Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
12.5 Middle East Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12.6 Middle East Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
13 Global Opioid Use Disorder Market Key Performance Indicators |
14 Global Opioid Use Disorder Market - Export/Import By Countries Assessment |
15 Global Opioid Use Disorder Market - Opportunity Assessment |
15.1 Global Opioid Use Disorder Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Opioid Use Disorder Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.3 Global Opioid Use Disorder Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
15.4 Global Opioid Use Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
15.5 Global Opioid Use Disorder Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
16 Global Opioid Use Disorder Market - Competitive Landscape |
16.1 Global Opioid Use Disorder Market Revenue Share, By Companies, 2024 |
16.2 Global Opioid Use Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |